Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2026-03-02 @ 4:11 AM
Study NCT ID:
NCT02530034
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-24
First Post:
2015-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | View |
| None | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | View |
| None | Hematopoietic and Lymphoid Cell Neoplasm | View |
| None | High Risk Myelodysplastic Syndrome | View |
| None | Myelodysplastic Syndrome With Excess Blasts-1 | View |
| None | Myelodysplastic Syndrome With Excess Blasts-2 | View |
| None | Myelofibrosis | View |
| None | Recurrent Acute Myeloid Leukemia | View |
| None | Recurrent Chronic Myelomonocytic Leukemia | View |
| None | Refractory Chronic Myelomonocytic Leukemia | View |
| None | Secondary Acute Myeloid Leukemia | View |
Keywords: